Back to search
FDAFDA · Food and drugs·Recall number D-0305-2026

Trazodone Hydrochloride, USP, 50 mg, 100-Count Bottle, Rx only, Manufactured by: Granules India Limited, Hyderabad, 500 081, India, Manufactured for: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-231-01.

Published February 11, 2026 · Recall initiated: January 26, 2026

Summary

FDA records drug Class II recall D-0305-2026, published February 11, 2026 and initiated January 26, 2026. Recalling firm: Granules Pharmaceuticals Inc.; Status: Ongoing; Reported quantity: 71424 bottles.; Lot: Batch # 6160008A, Exp Date: 12/31/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Tablets/Capsules

What to do

Voluntary: Firm initiated

Get an email if TRAZODONE HYDROCHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
TRAZODONE HYDROCHLORIDE
Manufacturer
Granules Pharmaceuticals Inc.
Distributor
US Nationwide.
UPC
0370010232013
Lot
Batch # 6160008A, Exp Date: 12/31/2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Trazodone Hydrochloride, USP, 50 mg, 100-Count Bottle, Rx only, Manufactured by: Granules India Limited, Hyderabad, 500 081, India, Manufactured for: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-231-01. recalled?

Yes. FDA published recall D-0305-2026 on February 11, 2026. Reported hazard: Presence of Foreign Tablets/Capsules

What should I do if I have this product?

Voluntary: Firm initiated

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: TRAZODONE HYDROCHLORIDE. UPC: 0370010232013.